List of bibliographic references
Number of relevant bibliographic references: 58.
[0-20] [
0 - 20][
0 - 50][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000011 (1999) |
J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. Malbezin | A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease. |
000069 (1999) |
Olga Corti [France] ; Amelia Sánchez-Capelo [France] ; Philippe Colin [France] ; Naïma Hanoun [France] ; Michel Hamon [France] ; Jacques Mallet [France] | Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson’s disease |
000091 (2000) |
T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E Gross | Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey. |
000099 (????) |
| [Parkinson disease]. |
000118 (2000) |
I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. Tison | Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. |
000125 (2000) |
R. Bordet [France] ; S. Ridray ; J C Schwartz ; P. Sokoloff | Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats. |
000162 (2001) |
B. Herer [France] ; I. Arnulf ; B. Housset | Effects of levodopa on pulmonary function in Parkinson's disease. |
000198 (2001) |
N. Callizot [France] ; J L Guénet ; C. Baillet ; J M Warter ; P. Poindron | The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome. |
000219 (2001) |
P. Krystkowiak [France] ; J L Blatt ; J L Bourriez ; A. Duhamel ; M. Perina ; G. Kemoun ; S. Blond ; J D Guieu ; A. Destée ; L. Defebvre | Chronic bilateral pallidal stimulation and levodopa do not improve gait in the same way in Parkinson's disease: a study using a video motion analysis system. |
000222 (2001) |
S. Thobois [France] ; S. Guillouet ; E. Broussolle | Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease. |
000224 (2002) |
Luc J P. Defebvre [France] ; Pierre Krystkowiak ; Jean-Louis Blatt ; Alain Duhamel ; Jean-Louis Bourriez ; Myriame Périna ; Serge Blond ; Jean-Daniel Guieu ; Alain Destée [France] | Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease. |
000259 (2002) |
André Nieoullon [France] | Dopamine and the regulation of cognition and attention. |
000261 (????) |
Bernard Bruguerolle [France] ; Nicolas Simon | Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. |
000268 (2002) |
Anne-Marie Bonnet [France] | [Alpha-2 adrenergic receptors and Parkinson's disease]. |
000436 (2004) |
Vincent Paillé [France] ; Philippe Brachet ; Philippe Damier | Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease. |
000460 (2004) |
Jean-Christophe Corvol [France] ; Marie-Paule Muriel ; Emmanuel Valjent ; Jean Féger ; Naïma Hanoun ; Jean-Antoine Girault ; Etienne C. Hirsch ; Denis Hervé | Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. |
000499 (2005) |
E. Bezard [France] ; C E Gross ; Li Qin ; V V Gurevich ; J L Benovic ; E V Gurevich | L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. |
000553 (2005) |
Olivier Rascol [France] | Rasagiline in the pharmacotherapy of Parkinson's disease--a review. |
000571 (2006) |
D. Guehl [France] ; P. Dehail ; M P De Sèze ; E. Cuny ; P. Faux ; F. Tison ; M. Barat ; B. Bioulac ; P. Burbaud | Evolution of postural stability after subthalamic nucleus stimulation in Parkinson's disease: a combined clinical and posturometric study. |
000657 (2006) |
Mauricette Brocco [France] ; Anne Dekeyne ; Mariusz Papp ; Mark J. Millan | Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. |
000788 (2008) |
Hervé Allain [France] ; Danièle Bentué-Ferrer ; Yvette Akwa | Disease-modifying drugs and Parkinson's disease. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (pharmacology)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i \
-Sk "Antiparkinson Agents (pharmacology)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= Antiparkinson Agents (pharmacology)
}}
| This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 | ![](Common/icons/LogoDilib.gif) |